UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  FORM 10-K/A
                               Amendment Number 1

[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
    ACT OF 1934 FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2012

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
    ACT OF 1934

                        Commission file number: 000-53850

                               MEDBOOK WORLD, INC.
             (Exact name of registrant as specified in its charter)

       DELAWARE                                                27-1397396
(State or Incorporation)                               (I.R.S. Employer Id. No.)

1150 Silverado, Ste. 204, La Jolla, CA  92037               (858) 459-1133
  (Address of principal executive offices)       (Registrant's telephone number)

           Securities registered pursuant to Section 12(b) of the Act:

                                      None

          Securities registered pursuant to Section 12(g) of the Act:

                    Common Stock, $0.0001 par value per share
                                (Title of Class)

Indicate by check mark if MedBook World, Inc. (MedBook) is a well-known seasoned
issuer, as defined in Rule 405 of the Securities Act of 1933. Yes [ ] No [X]

Indicate by check mark if MedBook is not required to file reports pursuant to
Section 13 or Section 15(d) of the Securities Exchange Act of 1934. Yes [ ] No
[X]

Indicate by check mark whether MedBook (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that MedBook was required to
file such reports), and (2) has been subject to such filing requirements for the
past 90 days. Yes [X] No [ ]

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405
of Regulation S-K is not contained herein, and will not be contained, to the
best of MedBook's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. [X]

Indicate by check mark whether MedBook is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting company.

Large accelerated filer [ ]                        Accelerated Filer [ ]
Non-accelerated filer [ ]                          Smaller reporting company [X]

Indicate by check mark whether MedBook is a shell company (as defined in Rule
12b-2 of the Exchange Act): Yes [X] No [ ]

The aggregate market value of MedBook's common stock held by non-affiliates of
MedBook as of the last business day of MedBook's most recently completed fiscal
quarter (September 30, 2012) was approximately $0.00 (based on lack of any trade
or posted price reported by OTC on or prior to September 30, 2012). For this
purpose, all of MedBook's officers and directors and their affiliates were
assumed to be affiliates of MedBook.

There were 11,150,000 shares of MedBook's common stock outstanding as of
December 10, 2012.

DOCUMENTS INCORPORATED BY REFERENCE: Form 10-K filed on December 18, 2012.
<PAGE>
                                EXPLANATORY NOTE

     The purpose of this Amendment No. 1 (this "Amendment No. 1") to the
Company's Annual Report on Form 10-K for the year ended September 30, 2012,
filed with the Securities and Exchange Commission on December 18, 2012 (the
"Form 10-K"), is to revise Item 9A, Controls and Procedures, and to revise the
opinion letters of our auditors to clarify, in the case of Stan Lee, the date of
his audit, and in the case of Anton & Chia, the date of our incorporation.

     No other changes have been made to the Form 10-K. This Amendment No. 1
speaks as of the original filing date of the Form 10-K and does not reflect
events that have occurred subsequent to the original filing date of the Form
10-K, and does not modify or update in any way disclosures made in the Form
10-K.

ITEM 1. DESCRIPTION OF BUSINESS

     Incorporated be reference to our 10-K filed on December 18, 2012.

ITEM 1A. RISK FACTORS

     Incorporated be reference to our 10-K filed on December 18, 2012.

ITEM 2. PROPERTIES

     Incorporated be reference to our 10-K filed on December 18, 2012.

ITEM 3. LEGAL PROCEEDINGS

            Incorporated be reference to our 10-K filed on December 18, 2012.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

     Incorporated be reference to our 10-K filed on December 18, 2012.

ITEM 5. MARKET FOR COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER
        PURCHASES OF EQUITY SECURITIES

     Incorporated be reference to our 10-K filed on December 18, 2012.

ITEM 6. SELECTED FINANCIAL DATA

     Incorporated be reference to our 10-K filed on December 18, 2012.

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATIONS

     Incorporated be reference to our 10-K filed on December 18, 2012.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

     Incorporated be reference to our 10-K filed on December 18, 2012.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

     The following documents are filed below as part of this report:

     Report of Independent Registered Public Accounting Firm, Anton & Chia, CPAs

     Report of Independent Registered Public Accounting Firm, Stan J. H. Lee,
     CPA

     All other elements of our Financial Statements are incorporated be
reference to our 10-K filed on December 18, 2012.

                                       2
<PAGE>
                        [LETTERHEAD OF ANTON & CHIA, LLP



             REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Stockholders' of
Medbook World, Inc.:

We have  audited  the  accompanying  balance  sheet of Medbook  World,  Inc.  (a
development  stage  company) (the  "Company") as of September 30, 2012,  and the
related  statements of operations,  changes in stockholders'  deficit,  and cash
flows  for the year  then  ended  and for the  period  from  November  17,  2009
(Inception)  through  September 30, 2012.  These  financial  statements  are the
responsibility of the Company's management.  Our responsibility is to express an
opinion on these financial statements based on our audits.

We conducted our audits in accordance  with the standards of the Public  Company
Accounting  Oversight Board (United States of America).  Those standards require
that we plan and perform the audits to obtain reasonable assurance about whether
the financial statements are free of material  misstatement.  The Company is not
required  to have,  nor were we engaged  to  perform,  an audit of its  internal
control over financial reporting.  Our audits included consideration of internal
control over financial  reporting as a basis for designing audit procedures that
are appropriate in the  circumstances,  but not for the purpose of expressing an
opinion on the  effectiveness  of the Company's  internal control over financial
reporting. Accordingly, we express no such opinion. An audit includes examining,
on a  test  basis,  evidence  supporting  the  amounts  and  disclosures  in the
financial statements. An audit also includes assessing the accounting principles
used and  significant  estimates made by  management,  as well as evaluating the
overall financial statement  presentation.  We believe that our audits provide a
reasonable basis for our opinion.

In our opinion,  the financial  statements referred to the above present fairly,
in all material  respects,  the financial  position of Medbook World, Inc. as of
September 30, 2012 and the results of its operations and cash flows for the year
then  ended and for the  period  from  November  17,  2009  (Inception)  through
September 30, 2012 in conformity with accounting  principles  generally accepted
in the United States of America.

The  accompanying  financial  statements  have been  prepared  assuming that the
Company will continue as a going concern. As shown in the financial  statements,
the Company has incurred an  accumulated  deficit of $181,151 from  inception to
September 30, 2012. This raises substantial doubt about the Company's ability to
continue  as a going  concern.  Management's  plans in regard to this matter are
described in Note 3. The  financial  statements  do not include any  adjustments
that might result from the outcome of this uncertainty.


/s/ Anton & Chia, LLP
--------------------------------
Newport Beach, California
December 10, 2012

                                       3
<PAGE>
                             Stan Jeong Ha Lee, CPA
             2160 North Central Rd. Suite 209 * Fort Lee * NJ 07024
                   P.O. Box 436402 * San Diego * CA 92143-6402
                          619-623-7799 Fax 619-564-3408
                            E-mail) stan2u@gmail.com


             REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders
MEDBOOK WORLD, INC.
(A Development Stage Company)

We have audited the  accompanying  balance  sheet of MEDBOOK  WORLD,  INC. as at
September  30,  2011 and the related  statements  of  operations,  shareholders'
deficit  and cash  flows  for the  fiscal  years  then  ended.  These  financial
statements   are  the   responsibility   of  the   Company's   management.   Our
responsibility  is to express an opinion on these financial  statements based on
our audit.

We conducted our audits in accordance  with the standards of the Public  Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements  are free of material  misstatement.  The Company is not  required to
have,  nor were we engaged to perform,  an audit of its  internal  control  over
financial reporting.  Our audit included  consideration of internal control over
financial  reporting  as  a  basis  for  designing  audit  procedures  that  are
appropriate  in the  circumstances,  but not for the purposes of  expressing  an
opinion on the  effectiveness  of the Company's  internal control over financial
reporting.  Accordingly, we express no such opinion. An audit includes examining
on a test basis,  evidence supporting the amount and disclosures in the combined
financial statements. An audit also includes assessing the accounting principles
used and  significant  estimates made by  management,  as well as evaluating the
overall financial statement  presentation.  We believe that our audit provides a
reasonable basis for our opinion.

In our opinion,  the financial  statements  referred to above present fairly, in
all material  respects,  the  financial  position of MEDBOOK  WORLD,  INC. as of
September 30, 2011,  and the results of its operation and its cash flows for the
aforementioned  periods in conformity with U.S.  generally  accepted  accounting
principles.

The  financial  statements  have been  prepared  assuming  that the Company will
continue  as a  going  concern.  As  discussed  in the  notes  to the  financial
statements,  the Company has not  established any source of revenue to cover its
operating costs and losses from operations  raises  substantial  doubt about its
ability to continue as a going concern.  The financial statements do not include
any adjustments that might result from the outcome of this uncertainty.


/s/ Stan Jeong Ha Lee, CPA
----------------------------------
Stan Jeong Ha Lee, CPA
December 19, 2011
Fort Lee, NJ

                                       4
<PAGE>
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
        FINANCIAL DISCLOSURE

     There have been no disagreements with our accountants and no changes to our
accounting and financial disclosure.

ITEM 9A. CONTROLS AND PROCEDURES

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

     Under the supervision and with the participation of our management,
including our principal executive officer and the principal financial officer,
we have conducted an evaluation of the effectiveness of the design and operation
of our disclosure controls and procedures, as defined in Rules 13a-15(e) and
15d-15(e) under the Securities and Exchange Act of 1934, as of the end of the
period covered by this report (September 30, 2012). Based on this evaluation,
our principal executive officer and principal financial officer concluded as of
the evaluation date that our disclosure controls and procedures were ineffective
such that the material information required to be included in our Securities and
Exchange Commission reports was not accumulated and communicated to our
management, including our principal executive officer and principal financial
officer, recorded, processed, summarized and reported within the time periods
specified in Securities and Exchange Commission rules and forms relating to our
company, particularly during the period when this report was being prepared.

MANAGEMENT'S ANNUAL REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

     Our management is responsible for establishing and maintaining adequate
internal control over financial reporting, as such term is defined in Rules
13a-15(f) and 15d-15(f) under the Exchange Act, for the company. Internal
control over financial reporting includes those policies and procedures that:
(1) pertain to the maintenance of records that, in reasonable detail, accurately
and fairly reflect the transactions and dispositions of our assets; (2) provide
reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with generally accepted
accounting principles, and that our receipts and expenditures are being made
only in accordance with authorizations of its management and directors; and (3)
provide reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of our assets that could have a
material effect on the financial statements.

     Management recognizes that there are inherent limitations in the
effectiveness of any system of internal control, and accordingly, even effective
internal control can provide only reasonable assurance with respect to financial
statement preparation and may not prevent or detect material misstatements. In
addition, effective internal control at a point in time may become ineffective
in future periods because of changes in conditions or due to deterioration in
the degree of compliance with our established policies and procedures. A
material weakness is a significant deficiency, or combination of significant
deficiencies, that results in there being a more than remote likelihood that a
material misstatement of the annual or interim financial statements will not be
prevented or detected.

     Under the supervision and with the participation of our chief executive
officer and our chief financial officer we conducted an evaluation of the
effectiveness of our internal control over financial reporting, as of September
30, 2012, based on the framework set forth in Internal Control-Integrated
Framework issued by the Committee of Sponsoring Organizations of the Treadway
Commission (COSO). Based on our evaluation under this framework, management
concluded that our internal control over financial reporting was not effective
as of the evaluation date due to the factors stated below.

                                       5
<PAGE>
     INSUFFICIENT RESOURCES: We have an inadequate number of personnel with
requisite expertise in the key functional areas of finance and accounting to be
able to have appropriately designed and operating entity level controls
including risk assessment; information and communication; monitoring; and
financial reporting.

     INADEQUATE SEGREGATION OF DUTIES: We have an inadequate number of personnel
to properly segregate duties to implement control procedures.

     LACK OF AUDIT COMMITTEE AND OUTSIDE DIRECTORS ON THE COMPANY'S BOARD OF
DIRECTORS: We do not have a functioning audit committee or outside directors on
our board of directors, resulting in ineffective oversight in the establishment
and monitoring of required internal controls and procedures.

     Management is committed to improving its internal controls and will (1)
continue to assess and address shortfalls in staffing and to assist the Company
with accounting and finance responsibilities, (2) increase the frequency of
independent reconciliations of significant accounts which will mitigate the lack
of segregation of duties until there are sufficient personnel and (3) may
consider appointing outside directors and audit committee members in the future.

         Management has discussed the material weakness noted above with our
independent registered public accounting firm. This annual report does not
include an attestation report of our registered public accounting firm regarding
internal control over financial reporting. Management's report was not subject
to attestation by our registered public accounting firm pursuant to temporary
rules of the SEC that permit us to provide only management's report in this
annual report.

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

     There have been no changes in the Company's internal controls over
financial reporting during its fiscal year that have materially affected, or are
reasonably likely to materially affect, its internal control over financial
reporting.

ITEM 9B. OTHER INFORMATION

     Not applicable.

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE

     Incorporated be reference to our 10-K filed on December 18, 2012.

ITEM 11. EXECUTIVE COMPENSATION

     Incorporated be reference to our 10-K filed on December 18, 2012.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND
         RELATED STOCKHOLDER MATTERS

     Incorporated be reference to our 10-K filed on December 18, 2012.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS AND DIRECTOR
         INDEPENDENCE

     Incorporated be reference to our 10-K filed on December 18, 2012.

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

     Incorporated be reference to our 10-K filed on December 18, 2012.

                                       6
<PAGE>
ITEM 15. FINANCIAL STATEMENTS AND EXHIBITS

     The following documents are filed as part of this report:

Exhibit No.
-----------

  31.1       Certification of Chief Executive Officer required by Rule 13a-14(a)
             or Rule 15d-14(a) of the Securities Exchange Act of 1934, as
             adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

  31.2       Certification of Chief Financial Officer required by Rule 13a-14(a)
             or Rule 15d-14(a) of the Securities Exchange Act of 1934, as
             adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

  32         Certification of Chief Executive Officer and Chief Financial
             Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section
             906 of the Sarbanes-Oxley Act of 2002

The following materials are incorporated by reference to our 10-K filed on
December 18, 2012:

  101        Annual Report on Form 10-K for the year ended September 30, 2012,
             formatted in XBRL (eXtensible Business Reporting Language); (i)
             Balance Sheets at September 30, 2012 and September 30, 2011, (ii)
             Statement of Operations for the years ended September 30, 2012 and
             2011, (iii) Statement of Changes in Stockholders' Equity since
             Inception, (iv) Statement of Cash Flows for the years ended
             September 30, 2012 and 2011, and (v) Notes to Financial Statements.

                                   SIGNATURES

     Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, MedBook World, Inc., the Registrant, has duly caused this
report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: February 4, 2013                     MEDBOOK WORLD, INC.


                                           By: /s/ Daniel Masters
                                               ---------------------------------
                                               Daniel Masters
                                               Chief Executive Officer


                                           By: /s/ Anthony Turnbull
                                               ---------------------------------
                                               Anthony Turnbull
                                               CFO, Secretary, and Director

                                       7